Micafungine versus placebo au cours du sepsis nosocomial chez des patients multi-colonisés à candida : Essai randomisé contrôlé EMPIRICUS - EMPIRICUS

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-005451-14-FR

Enrollment

Unknown

Registered

2011-11-18

Start date

2011-12-07

Completion date

Unknown

Last updated

2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Mycamine Pharmaceutical Form: Powder for solution for infusion CAS Number: 208538-73-2 Other descriptive name: MICAFUNGIN SODIUM Concentration unit: mg milligram(s) Concentration type: equ

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: day 28	—

Secondary

Measure	Time frame
Timepoint(s) of evaluation of this end point: day 28 and day 90	—

Countries

France

Outcome results